Hepatica Invest Aktiebolag

ABActive

Org 5566962899Economic activity was not specified by tax authority · NACE 0000Est. 20060 employees

Overview Financials People & ownership Related companies

Hepatica Invest Aktiebolag is a Swedish AB, operating in the Huvudnäring okänd sector. Incorporated in 2006, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

+3642% vs 2023

Equity ratio

89.8%

Financial strength

Net profit 2024

SEK 4,7M

+112495% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK 149K	+3642%
Net profit	SEK 4,7M	+112495%
Total assets	SEK 5,6M	+1783%
Equity	SEK 5M	+1652%
Employees	0	—

Contact

Address

magnus@ledin.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Hepatica Invest Aktiebolag?

Hepatica Invest Aktiebolag is registered with Bolagsverket / SCB under Org 5566962899.

Who is the CEO of Hepatica Invest Aktiebolag?

Magnus Carl Håkan Ledin is Chief Executive Officer of Hepatica Invest Aktiebolag, in role since 2022.

Who is the chairman of Hepatica Invest Aktiebolag?

Veronica Elena Ledin chairs the board of Hepatica Invest Aktiebolag, in role since 2022.

Hepatica Invest Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Hepatica Invest Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Hepatica Invest Aktiebolag